Methylpiperidino pyrazole
(Synonyms: MPP) 目录号 : GC17161
Methylpiperidino pyrazole是一种对雌激素受体α（Erα）具有高度选择性的拮抗剂，其半数抑制浓度（IC50）为20.01nM。
Cas No.:289726-02-9
Sample solution is provided at 25 µL, 10mM.
Methylpiperidino pyrazole is a highly selective estrogen receptor α (Erα) antagonist with an IC50 value of 20.01nM[1]. Methylpiperidino pyrazole binds selectively to ESR1 rather than ESR2 and exhibits both agonistic and antagonistic actions in cultured target cells of uterine origin as well as in the uteri of mice[2]. Methylpiperidino pyrazole also has the ability to attenuate osteoblast maturation[3].
In vitro, MCF-7 cells pretreated with Methylpiperidino pyrazole (100nM) for 30 minutes completely inhibited cell proliferation induced by bisphenol S (BPS) (10μM; 72h) and specifically suppressed the increase of S phase induced by BPS[4]. The treatment of glioblastoma (GBM) cells with Methylpiperidino pyrazole at a concentration of 1μM for a duration of 2 hours effectively blocked the ability of estradiol (E2) to enhance the migration and invasion capabilities of these GBM cells[5].
In vivo, intraperitoneal injection of E2 (0.5μg/gbw) in male adult pompano fish was significantly attenuated in the up-regulation of Erα, estrogen receptors β2 (Erβ2), vitellogenin-B (vtg-B), and vtg-C by Methylpiperidino pyrazole, which also promoted the expressions of erβ1 and vtg-A[6]. Ovariectomized wild-type (WT) and estrogen receptor-β knockout (ERβKO) CF1 mice were treated with Methylpiperidino pyrazole (25, 50, 100, or 150mg; i.p.), which significantly increased uterine weight and cell proliferation[7].
References:
[1] Karaboğa Arslan AK, Yerer MB. α-Chaconine and α-Solanine Inhibit RL95-2 Endometrium Cancer Cell Proliferation by Reducing Expression of Akt (Ser473) and ERα (Ser167). Nutrients. 2018;10(6):672.
[2] Davis AM, Mao J, Naz B, Kohl JA, Rosenfeld CS. Comparative effects of estradiol, methyl-piperidino-pyrazole, raloxifene, and ICI 182 780 on gene expression in the murine uterus. J Mol Endocrinol. 2008;41(4):205-217.
[3] Rodriguez-Merchan, E.C. The importance of smoking in orthopedic surgery. Hosp. Pract. 2018, 46, 175–182.
[4] Lin Z, Zhang X, Zhao F, Ru S. Bisphenol S promotes the cell cycle progression and cell proliferation through ERα-cyclin D-CDK4/6-pRb pathway in MCF-7 breast cancer cells. Toxicol Appl Pharmacol. 2019;366:75-82.
[5] Hernández-Vega AM, Del Moral-Morales A, Zamora-Sánchez CJ, Piña-Medina AG, González-Arenas A, Camacho-Arroyo I. Estradiol Induces Epithelial to Mesenchymal Transition of Human Glioblastoma Cells. Cells. 2020;9(9):1930.
[6] Li X, Brighton Ndandala C, Zhou Q, Huang C, Li G, Chen H. Molecular cloning of estrogen receptor and its function on vitellogenesis in pompano (Trachinotus ovatus). Gen Comp Endocrinol. 2024;346:114403.
[7] Davis AM, Ellersieck MR, Grimm KM, Rosenfeld CS. The effects of the selective estrogen receptor modulators, methyl-piperidino-pyrazole (MPP), and raloxifene in normal and cancerous endometrial cell lines and in the murine uterus. Mol Reprod Dev. 2006;73(8):1034-1044.
Methylpiperidino pyrazole是一种对雌激素受体α（Erα）具有高度选择性的拮抗剂，其半数抑制浓度（IC50）为20.01nM[1]。Methylpiperidino pyrazole选择性地与ESR1而非ESR2结合，并在培养的子宫源性靶细胞以及小鼠子宫中展现出激动剂和拮抗剂的双重作用[2]。Methylpiperidino pyrazole还可以抑制成骨细胞的成熟[3]。
在体外，经Methylpiperidino pyrazole（100nM）预处理30分钟的MCF-7细胞，能够完全抑制双酚S（BPS，10μM；72h）诱导的细胞增殖，并特异性地抑制BPS诱导的S期增加[4]。1μM的Methylpiperidino pyrazole处理2h，可以阻断雌二醇（E2）增加胶质母细胞瘤（GBM）细胞迁移和侵袭的能力[5]。
在体内，成年雄性pompano鱼经腹腔注射E2（0.5μg/gbw）后，Methylpiperidino pyrazole显著抑制了Erα、雌激素受体β2（Erβ2）、卵黄蛋白B（vtg-B）和vtg-C的上调，同时促进了erβ1和vtg-A的表达[6]。对野生型（WT）和雌激素受体β敲除（ERβKO）的去卵巢CF1小鼠进行Methylpiperidino pyrazole（25、50、100或150mg；腹腔注射）处理，显著增加了子宫重量和细胞增殖[7]。
| Cell experiment [1]: | |
Cell lines | MCF-7 cells |
Preparation Method | MCF-7 cells were pretreated for 30min with selective inhibitors, Methylpiperidino pyrazole (100nM) for estrogen receptor alpha (Erα), and then treated with 10μM bisphenol S (BPS) for 72h, and subjected to CCK8 assay. |
Reaction Conditions | 100nM; 30min |
Applications | 10μM BPS significantly increased cell proliferation, and 100nM Methylpiperidino pyrazole completely inhibited the cell proliferation induced by BPS. Consistent with the inhibition of cell proliferation results, BPS significantly increased the percentage of S phase, and 100nM Methylpiperidino pyrazole specifically suppressed the increase of S phase induced by BPS. |
| Animal experiment [2]: | |
Animal models | CF1 mice |
Preparation Method | The mice were ovariectomized at 7-9 weeks of age. One week after the surgery, CF1 mice were intritoneaperally injected with Methylpiperidino pyrazole at doses of 25mg (n=3), 50mg (n=11), 100mg (n=5), or 150mg (n=3), or with vehicle alone (n=20). On the third day, the mice were humanely euthanized by CO2 inhalation. The uterus was then collected, weighed, and fixed in 10% neutral buffered formalin (NBF). |
Dosage form | 25, 50, 100, or 150mg; i.p. |
Applications | Treatment of ovariectomized mice with 25, 50, or 100mg of Methylpiperidino pyrazole significantly increased the average uterine wet weight-to-body weight ratio. A dose of 150mg of Methylpiperidino pyrazole resulted in a decrease in the average uterine wet weight-to-body weight ratio. Ovariectomized mice treated with Methylpiperidino pyrazole also exhibited increased proliferation, as evidenced by an increase in Ki67-positive staining in the endometrial cells. |
References: | |
| Cas No. | 289726-02-9 | SDF | |
| 别名 | MPP | ||
| 化学名 | 4-[1-(4-hydroxyphenyl)-4-methyl-5-[4-[2-(1-piperidinyl)ethoxy]phenyl]-1H-pyrazol-3-yl]-phenol | ||
| Canonical SMILES | CC1=C(C2=CC=C(OCCN3CCCCC3)C=C2)N(C4=CC=C(O)C=C4)N=C1C5=CC=C(O)C=C5 | ||
| 分子式 | C29H31N3O3 | 分子量 | 469.6 |
| 溶解度 | ≤3mg/ml in ethanol;5mg/ml in DMSO;14mg/ml in dimethyl formamide | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.1295 mL | 10.6474 mL | 21.2947 mL |
| 5 mM | 0.4259 mL | 2.1295 mL | 4.2589 mL |
| 10 mM | 0.2129 mL | 1.0647 mL | 2.1295 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet